Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell)
2 clinical trials · Condition
◉ Watch Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell)
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Milatuzumab for Graft Versus Host Disease (NCT01663766) | Gilead Sciences | 2013-12-01 |
Track Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell) automatically
Every clearance here is in the API, with alerts when new ones post.